198 related articles for article (PubMed ID: 35116817)
21. Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Wen DY; Huang JC; Wang JY; Pan WY; Zeng JH; Pang YY; Yang H
Oncol Lett; 2018 Dec; 16(6):6918-6929. PubMed ID: 30546424
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Pan WY; Zeng JH; Wen DY; Wang JY; Wang PP; Chen G; Feng ZB
Oncol Lett; 2019 Feb; 17(2):1695-1713. PubMed ID: 30675229
[TBL] [Abstract][Full Text] [Related]
23. Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses.
Yang H; Zhang L; Wang XD; Huang ML; Lin P; Pang YY; Feng ZB; Chen G
Int J Clin Exp Pathol; 2018; 11(3):1123-1134. PubMed ID: 31938207
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
25. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G
Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959
[TBL] [Abstract][Full Text] [Related]
26. miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.
Xu J; Lv H; Zhang B; Xu F; Zhu H; Chen B; Zhu C; Shen J
J Thorac Dis; 2019 Jul; 11(7):3015-3029. PubMed ID: 31463131
[TBL] [Abstract][Full Text] [Related]
27. LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1.
Wu Y; Li L; Wang Q; Zhang L; He C; Wang X; Liu H
Transl Lung Cancer Res; 2020 Aug; 9(4):1138-1148. PubMed ID: 32953492
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Gan XN; Luo J; Tang RX; Wang HL; Zhou H; Qin H; Gan TQ; Chen G
Tumour Biol; 2017 May; 39(5):1010428317705755. PubMed ID: 28488527
[TBL] [Abstract][Full Text] [Related]
29. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.
Zhong XZ; Deng Y; Chen G; Yang H
Oncol Lett; 2019 Jan; 17(1):230-246. PubMed ID: 30655760
[TBL] [Abstract][Full Text] [Related]
32. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
[TBL] [Abstract][Full Text] [Related]
33. miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting
Qi Y; Hou Y; Qi L
J Environ Sci Health C Toxicol Carcinog; 2021; 39(3):251-268. PubMed ID: 34165043
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA LINC00511 promotes proliferation, invasion, and migration of non-small cell lung cancer cells by targeting miR-625-5p/GSPT1.
Cheng Y; Wang S; Mu X
Transl Cancer Res; 2021 Dec; 10(12):5159-5173. PubMed ID: 35116366
[TBL] [Abstract][Full Text] [Related]
35. Integrating microRNA expression, miRNA-mRNA regulation network and signal pathway: a novel strategy for lung cancer biomarker discovery.
Nie R; Niu W; Tang T; Zhang J; Zhang X
PeerJ; 2021; 9():e12369. PubMed ID: 34754623
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
Chen SW; Lu HP; Chen G; Yang J; Huang WY; Wang XM; Huang SP; Gao L; Liu J; Fu ZW; Chen P; Zhai GQ; Luo J; Li XJ; Huang ZG; Li ZY; Gan TQ; Yang DP; Mo WJ; Zhou HF
FEBS Open Bio; 2020 Aug; 10(8):1624-1641. PubMed ID: 32598517
[TBL] [Abstract][Full Text] [Related]
37. miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting
Shan X; Zhang C; Li C; Fan X; Song G; Zhu J; Cao R; Zhang X; Zhu W
Cancer Pathog Ther; 2023 Apr; 1(2):87-97. PubMed ID: 38328402
[TBL] [Abstract][Full Text] [Related]
38. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
39. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
Luo YH; Tang W; Zhang X; Tan Z; Guo WL; Zhao N; Pang SM; Dang YW; Rong MH; Cao J
Medicine (Baltimore); 2017 Jul; 96(30):e7545. PubMed ID: 28746200
[TBL] [Abstract][Full Text] [Related]
40. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
